Trillium Health Partners’ Post

Can Britain lead a biotech revolution? Hard yes was the view of the panel at our Tony Blair Institute for Global Change event in partnership with Google DeepMind (thanks for being such brilliant hosts). My key takeaways from Benedict Macon-Cooney Sajid Javid Sarah Korman and Hans Bishop Altos Labs were that: - Healthcare needs a revolution to become much more prevention focused and biotech can supercharge that revolution - The UK can and must leverage its world-class science base to become a world leader - But there needs to be much better access to finance for companies in their growth phase - There also needs to be far greater public-private collaboration esp on utilising biomedical data for public and economic good, with all of the right privacy precautions in place and royalties fed back into the NHS - We need to invest now in the right infrastructure to build an NHS Data Trust - Lastly, and importantly, that this revolution in healthcare must be designed for everyone regardless of race or gender #biotech #healthcare #nhs #changemakers

🔍 Informed Consent: The Heart of Ethical Clinical Research 📝 Before a single data point is collected or a treatment is tested, there’s a critical step that ensures clinical research remains ethical and transparent—Informed Consent. It’s more than just a signature on a page. It’s about making sure participants understand the risks, benefits, and purpose of a study. It’s about empowering patients to make informed decisions, respecting their autonomy, and building trust. Informed consent is where science and humanity meet, ensuring that research moves forward ethically, with patients at the center of every study. Let’s give a shoutout to all the researchers who prioritize clarity and compassion in the consent process! 🙌 Follow ClinMastery #ClinicalResearch #InformedConsent #EthicsInResearch #PatientCentricity #ResearchEthics #Transparency

Diversifying clinical trial research. Creating a more inclusive workforce. Providing opportunity and economic outcomes for businesses with diverse ownership, control or operations. These are just some of the ways we're working to create a healthier, more equitable world. Read more about our progress: https://lnkd.in/e7AVBUDS

Excited to share Northwestern Medicine International Health's new publication, in the Management in Healthcare Journal, on navigating the ethics of global healthcare! Our innovative approach bridges cultural differences and upholds patient autonomy, ensuring informed consent while respecting diverse preferences. Check out how we’re making strides in ethical care at Northwestern Medicine International Health! #GlobalHealthcare #MedicalEthics #InformedConsent #PatientAutonomy #NMBetter https://lnkd.in/e7kqvwVC

When women are enabled to reach their full potential, everyone benefits. But severe inequities in health outcomes — especially related to maternal and reproductive care — currently place women around the world at risk. Throughout her work at BCG, Sarah Chamberlain has discovered the urgent need to enhance both funding and innovation in women's health care. She's found that, although the tools to ensure better outcomes exist, we need collaboration from innovators, payors, and providers to make them more accessible. Learn more about how cross-sector investment can make a real change in women's health care: https://lnkd.in/e7C_ADR4

REGISTER NOW! Explore actionable strategies to operationalize access and inclusion in research. Join Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center), Association for the Accreditation of Human Research Protection Programs, Inc. (AAHRPP), PRIM&R – Public Responsibility in Medicine and Research, and Mass General Brigham and learn about the Research Ethics Action Collaborative for HRPPs (REACH) initiative. https://lnkd.in/g2enANpa This Thursday, March 7, from 12 – 1 PM ET. Discussion topics: (1) Making the Case for Leadership, (2) Establishing a Roadmap for Change, (3) Presenting Resources, and (4) Soliciting Examples. https://lnkd.in/g2enANpa

As AI continues to reshape every facet of healthcare, what does that mean for planning and responding to crisis scenarios. Join crisis and communications experts Steve Behm, Practice Lead for Crisis and Reputation at Real Chemistry and Eric McNulty, Associate Director of the National Preparedness Leadership Initiative (NPLI), for an engaging discussion about the powerful impact of AI in managing healthcare crises and more. Register here: https://bit.ly/3LBkf4i

Great time in Worcester yesterday at the NE HIMSS Digital Health annual event. Many thanks to Marie Maloney and Bruno Nardone, MHSA, FACHE and the other members of our Digital Health Committee but creating a great opportunity for learning, sharing of ideas, and of course, networking. The last session of the day, the panel which is highlighted in the post below, was one of my favorites. In addition to the great take-aways mentioned in the post, wanted to add two that I heard. First, the investor community seems mostly focused on solutions that improve workforce issues and reducing administrative overhead, such as prior authorizations, as these were the pain points they have heard from the provider community. ROI was mentioned several times but interestingly, much less focus on improving clinical outcomes. Second, while the holy grail will always be to sell to large enterprise clients, this isn't a practical way to enter the market. Start small with FQHCs, Community Hospitals, and smaller ambulatory practices. These organizations don't require the customization that is needed with the large institutions and they have many burning problems that need addressing. The sale cycles are shorter and the expectations are lower.

As AI continues to reshape every facet of healthcare, what does that mean for planning and responding to crisis scenarios. Join crisis and communications experts Steve Behm, Practice Lead for Crisis and Reputation at Real Chemistry and Eric McNulty, Associate Director of the National Preparedness Leadership Initiative (NPLI), for an engaging discussion about the powerful impact of AI in managing healthcare crises and more. Register here: https://bit.ly/3LBkf4i

As technology grows more advanced, we tend to grow more human and connected alongside it. Join me this Friday at SXSW with Dr. Nasim Afsar, MD MBA MHM , Dr. Michelle Nichols, MD, MS, MBA, FAAFP and Benjamin Rolnik as we discuss Tech’s Role in Equity and Value-based Care.   "Discover how technology, value-based care, and social determinants intertwine to revolutionize health equity. Our panel of experts will discuss strategies for bridging care gaps, delve into policies fostering inclusive health systems, and explore the technology enhancing health equity now and the innovations that will improve care outcomes for all in the future. Join us for an insightful session on shaping a more equitable healthcare future."   SXSW https://lnkd.in/e3ai8nib Oracle Health https://lnkd.in/epyzHnAX   Oracle Stanford University School of Medicine Meharry Medical College SXSW #ai #ml #vbc #sdoh #healthequity